Article

ForbesForbes on 2024-05-08 15:30

Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?

The recent rise can be attributed to the progress with its weight-loss drug — MariTide and its upbeat Q1 results reported last week.

Related news